Automatic Website Traffic RSS


US   France   Germany   Spain   Netherlands  

Dmards | AutoTraffic

Updated recommendations for psoriatic arthritis

Psoriatic arthritis (PsA) is an autoimmune inflammatory disease. It has both joint and non-joint symptoms and manifestations, which can vary from person to person. It is commonly associated with ... read more

Psoriatic Arthritis: Updated Guideline Clarifies Treatment Sequence

Covering the full range of available disease-modifying anti-rheumatic drugs (DMARDs) -- including conventional, biologic, and targeted oral agents -- the new guideline comes with an easy-to-follow ... read more

Your Guide To Axial Spondyloarthritis Treatments

DMARDs are medications designed to decrease inflammation and pain, reduce tissue damage, and slow the progression of disease. They all require a prescription. There are many medications in this class, ... read more

No Rise in Cancer Risk Seen With Non-TNF Inhibitor Biologics in Rheumatoid Arthritis

Treatment of patients with rheumatoid arthritis (RA) with non-tumor necrosis factor inhibitor (TNFi) biologic disease-modifying antirheumatic drugs (bDMARDs) may not pose an increased risk for cancer, ... read more

Patients With Rheumatoid Arthritis Face a Nearly 40% Greater Risk for Major Osteoporotic Fractures

Researchers explored whether patients with rheumatoid arthritis, particularly those receiving DMARDs, are at an elevated risk for major osteoporotic fractures. read more

Rheumatoid Arthritis Therapeutics Market Beating Historical Challenges, What’s Next

Product segments include biologics and non-biologics, with non-biologics further categorized into NSAIDs, DMARDs, and others. Distribution channels comprise hospital pharmacies, retail pharmacies, and ... read more

Low-Dose Glucocorticoids in RA May Raise Cardiovascular Risks Without Improving Disease Control

Researchers assessed the safety and efficacy of very low-dose glucocorticoids used concomitantly with b/tsDMARDs among patients with rheumatoid arthritis. read more

Rheum Workforce May Have Grown, But It's Still Not Enough

The US rheumatology workforce grew by more than 20% from 2009 to 2019, according to new research, but even if this growth continued, it would not be enough to meet the increasing demand. read more

Valley Fever Screens Found Lagging for Rheum Patients in Endemic Areas

Medicare data indicated that most patients with rheumatologic conditions and living in areas where valley fever (aka coccidioidomycosis) is endemic were not screened for the disease before starting ... read more

‘Timely treatment can limit disability in children with Juvenile Arthritis’, say experts

On World Young Rheumatic Disease Day marked on March 18, experts draw attention to raising awareness and knowledge to help in the early diagnosis of rheumatic diseases among young people. read more

FDA Approves Tocilizumab Biosimilar for IV and Subcutaneous Administration

Tyenne, an interleukin-6 (IL-6) receptor antagonist, is indicated for the treatment of: Adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to 1 or more ... read more

Rheumatoid Arthritis Drugs Market Size to Worth USD 27.38 Bn by 2033

The global rheumatoid arthritis drugs market size is calculated at USD 18.27 billion for 2024 and is estimated to be worth around USD 27.38 billion by 2033, growing at a CAGR of 4.6% from 2023 to 2033 ... read more
Subscribe to RSS Feed

Auto Traffic generator Powered by. Full RSS Feed | Article Generator | Contact Us